Uncategorized
Nura Bio Launches to Discover and Develop Neuroprotective Drugs, Backed by $73 Million Series A Financing
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nura Bio Inc., a biopharma company created to discover and develop life-changing neuroprotective drugs, today announced its official launch. Alpna Seth, PhD, a leader in the global biotechnology industry, is President and Chief Executive Officer of Nura Bio. The Column Group led the company’s $73 million Series A round of financing as a syndicate together with Samsara BioCapital and Euclidean Capital. Nura Bio seeks to alter the course of neurologic